PT-141
Boosts desire by working on your brain — not just blood flow
Activates sexual desire in the brain.
Unlike PDE5 inhibitors, bremelanotide works centrally — binding melanocortin receptors (MC4R) in the hypothalamus to trigger genuine sexual desire, not just blood flow.
- FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in women.
- Effective regardless of whether the primary issue is vascular.
- Commonly produces flushing and brief nausea in the first 30 minutes.
PT-141 is different from Viagra or Cialis. Those work on blood flow. PT-141 works on your brain's desire center — it actually makes you want it more, not just able to do it. It flips switches in your brain's reward system to increase arousal and desire. It's FDA-approved for women with low desire, and works for men too. Take it about 45 minutes before you need it.
How long it stays, how it leaves.
Fixed dosing — not weight-adjusted. The calculator handles reconstitution math for common vial sizes so you inject the right volume every time.
Three tiers, three goals.
Start your first time at 500 mcg — about 40% of people get nausea, and higher doses make it worse. Find your effective dose before increasing.
Don't use more than once in 24 hours
Max 8 doses per month (FDA guidance)
What people actually report.
- Nausea (very common — about 40%)
- Flushing
- Headache
- Temporary skin darkening
Before you start.
- FDA-approved (sold as Vyleesi) for low desire in women
- About 40% of users experience nausea — it's the most common reason people stop using it
- Start at 500 mcg your first time, not 1000 mcg — find your minimum effective dose before going higher
- Taking it on an empty stomach or with just water can help with nausea
- Don't use more than once in 24 hours, and no more than 8 times per month (FDA guidance)
- Not recommended with high blood pressure or heart conditions